Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Major Shareholding Notification 2016

Dec 20, 2016

4017_mrq_2016-12-20_956930dd-f3d5-42c5-b0b8-8df3d561deb6.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Transparency notification

Brussels (Belgium), 20 December 2016 – 20:00 (CET) – regulated information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification dated 15 December 2016, from BlackRock, Inc. (having its registered offices at 55 East 52nd Street, New York, NY, 10055, U.S.A.).

BlackRock, Inc. has notified that, following a disposal of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV had decreased and has crossed downward the 3% minimum threshold.

On 13 December 2016, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 742 848 UCB shares with voting rights (versus 5 840 557 UCB shares in its previous notification dated 12 December 2016), representing 2.95% of the total number of shares issued by the company (194 505 658) (versus 3.00% in the notification dated 12 December 2016).

2. Content of the notification

The transparency notification dated 15 December 2016 included the following information:

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights
  • Notification by: A parent undertaking or a controlling person.
  • Persons subject to the notification requirement:
Name Address (for legal entities)
BlackRock, Inc 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Max-Joseph-Straße 6, Munich, 80333, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan
  • Date on which the threshold is crossed: 13 December 2016.
  • Threshold crossed (in %): 3%.
  • Denominator: 194 505 658.
  • Notified details:

UCB
News

A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc $\mathbf{0}$ $\overline{0}$ 0,00%
BlackRock (Netherlands) B.V. 19.816 19.816 0,01%
BlackRock (Singapore) Limited 7.217 7.217 0,00%
BlackRock Advisors (UK) Limited 925.459 829.231 0,43%
BlackRock Advisors, LLC 51.925 51.925 0,03%
BlackRock Asset Management
61.015
Canada Limited
61.015 0,03%
BlackRock Asset Management
Deutschland AG
222.966 223.206 0,11%
BlackRock Asset Management North
Asia Limited
644 644 0,00%
BlackRock Financial Management,
Inc.
81.434 81.434 0,04%
BlackRock Fund Advisors 1.779.288 1.772.924 0,91%
BlackRock Institutional Trust
2.066.009
Company, National Association
2.059.707 1,06%
BlackRock International Limited 14.159 12.706 0,01%
BlackRock Investment Management
(Australia) Limited
41.549 41.549 0,02%
BlackRock Investment Management
(UK) Limited
164.329 162.867 0,08%
BlackRock Investment Management,
LLC
237.515 237.680 0,12%
BlackRock Japan Co., Ltd. 167.232 180.927 0,09%
Subtotal
5.840.557
5.742.848 2,95%
TOTAL 5.742.848 0 2,95% 0,00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent 133.099 0,07% physical
BlackRock Fund Advisors Securities Lent 1.118 0,00% physical
BlackRock Institutional Trust
Company, National Association
Securities Lent 9.606 0,00% physical
BlackRock Institutional Trust
Company, National Association
Contract for Difference 65.447 0,03% cash
BlackRock International Limited Contract for Difference 10.772 0,01% cash
BlackRock Investment Management
(UK) Limited
Contract for Difference 158.896 0,08% cash
kRock Institutional Trust
pany, National Association
Contract for Difference 65.447 0.03% cash
kRock International Limited Contract for Difference 10.772 0.01% cash
kRock Investment Management
Limited
Contract for Difference 158,896 0.08% cash
TOTAL 378,938 0,19%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 6.121.786 3,15%

Chain of controlled undertakings through which the holding is effectively held:

Please see the full chain of control in the PDF which is attached to the notification.

Additional information:

The disclosure obligation arose due to voting rights for BlackRock, Inc. going below 3%.

3. Further information

This press release and the detailed transparency notification is available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be included in the corporate governance charter of UCB SA/NV, which is available on its website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 3.9 billion in 2015. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news